Incidence of, risk factors for and impact of readmission for heart failure after successful transcatheter aortic valve implantation

Archive ouverte

Guedeney, Paul | Huchet, François | Manigold, Thibaut | Rouanet, Stéphanie | Balagny, Pauline | Leprince, Pascal | Lebreton, Guillaume | Letocart, Vincent | Barthelemy, Olivier | Vicaut, Eric | Montalescot, Gilles | Guerin, Patrice | Collet, Jean-Philippe

Edité par CCSD ; Elsevier ; Société française de cardiologie [2008-....] -

International audience. Background: The incidence of and risk factors for readmission for heart failure after successful transcatheter aortic valve implantation (TAVI) are unclear.Aims: We sought to evaluate the incidence of, risk factors for and clinical impact of readmission for heart failure after successful TAVI in an unselected patient population.Methods: All patients who underwent successful TAVI in two high-volume French tertiary centres from February 2010 to December 2016 were included prospectively and followed up for 1 year. A Cox multivariable model was used to assess risk factors for readmission for heart failure and mortality.Results: A total of 1139 patients (mean age 82.4±7.7years; 52.2% male sex) were included. Readmission for heart failure occurred in 99 (9.2%) patients. Risk factors for readmission for heart failure were previous atrial fibrillation (adjusted hazard ratio [adjHR] 1.62, 95% confidence interval [CI] 1.09-2.40), diabetes mellitus (adjHR 1.67, 95% CI 1.11-2.50), chronic kidney disease (adjHR 1.72, 95% CI 1.13-2.62), chronic pulmonary disease (adjHR 1.81, 95% CI 1.17-2.81) and left ventricular ejection fraction after TAVI ≤ 35% (adjHR 2.12, 95% CI 1.20-3.75). Readmission for heart failure was strongly associated with mortality (adjHR 3.11, 95% CI 1.95-4.94), along with increased Society of Thoracic Surgeons' score (adjHR 1.07, 95% CI 1.03-1.12), chronic pulmonary disease (adjHR 1.45, 95% CI 1.00-2.09), previous atrial fibrillation (adjHR 2.11, 95% CI 1.52-2.93) and shock during the index hospitalization (adjHR 2.56, 95% CI 1.41-4.65).Conclusions: Readmission for heart failure occurs in one in 10 patients after successful TAVI, and is a strong risk factor for mortality. Co-morbidities and left ventricular ejection fraction after TAVI≤35% are the main risk factors for readmission for heart failure.

Suggestions

Du même auteur

Effect of oral anticoagulation on clinical outcomes and haemodynamic variables after successful transcatheter aortic valve implantation. Impact du traitement anticoagulant oral dans le devenir clinique et l’évolution des paramètres hémodynamique après un remplacement valvulaire aortique percutanée

Archive ouverte | Guedeney, Paul | CCSD

International audience. BackgroundThe effect of oral anticoagulation on clinical and haemodynamic outcomes following successful transcatheter aortic valve implantation is unclear.AimsTo evaluate the effect of oral a...

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

Archive ouverte | Guedeney, Paul | CCSD

International audience

Clinical outcomes according to ECG presentations in infarct-related cardiogenic shock in CULPRIT-SHOCK

Archive ouverte | Zeitouni, Michel | CCSD

International audience. BackgroundThe impact of ECG presentations of acute myocardial infarction (AMI) in cardiogenic shock is unknown.Research questionIn myocardial infarction with cardiogenic shock, is there a dif...

Chargement des enrichissements...